Powered by OpenAIRE graph
Found an issue? Give us feedback

UFC

University of Franche-Comté
Funder
Top 100 values are shown in the filters
Results number
arrow_drop_down
165 Projects, page 1 of 33
  • Funder: European Commission Project Code: 226017
    more_vert
  • Funder: European Commission Project Code: 660718
    Overall Budget: 173,076 EURFunder Contribution: 173,076 EUR

    Humans modify ecosystems to maximise benefits from natural resources and as a result wildlife adapts ecological relationships. For instance, voles show multiannual population cycles and predators respond numerically, possibly limiting vole populations. Voles also damage crops and reduce food available for livestock. Subsequently, farmers respond using anticoagulant rodenticides (ARs) to control voles. That means indirect control of predators by secondary exposure or by reduction of food sources. Therefore, ARs will be acting analogously as a superpredator, impeding the natural autoregulation of vole populations. Here the Experienced Researcher will become an ecologist and ecotoxicologist and learn to use cutting-edge Bayesian state space models to determine the superpredator role of ARs in both predator and prey dynamics. To do that, he will work in the Universities of Franche-Comté (UFC, France) and Aberdeen (UNIABDN, UK), the Doubs Hunting Federation (FDC25), but also work hand-in-hand with farmers, stakeholders, etc. about vole populations in western Europe. He will also collaborate with small mammal work groups involved in research about small mammal surges. By combining multidisciplinary and intersectoral knowledge, the project will address the deleterious effect of pest control by poisoning ecosystems. In addition, it will show predation as one underestimated tool for pest control. By direct contact with interested parties, the Experienced Researcher will become fully involved with groups related to the hunting industry, among others, which will enable him to develop consultancy services about small mammal pests and control methods. He will also boost his research carrier and become a senior post-doc dealing with strongly applied issues of ecology and ecotoxicology with strong links between international research institutions, maximising the chances to get a permanent position.

    more_vert
  • Funder: European Commission Project Code: 219412
    more_vert
  • Funder: French National Research Agency (ANR) Project Code: ANR-23-GURE-0012
    Funder Contribution: 1,050,000 EUR
    more_vert
  • Funder: European Commission Project Code: 796245
    Overall Budget: 173,076 EURFunder Contribution: 173,076 EUR

    Squalene is a natural lipid precursor, which plays a crucial role in the biosynthesis of sterols in the cells . Squalene is 100% biocompatible, not toxic and is able to enter into the cells easily. This makes it very promising for creating highly efficient drugs and drug delivery systems. The so-called squalenoylation technology is based on fusing hydrophobic squalenic acid with the molecules of water-soluble drugs. Resulting conjugated molecules spontaneously self-assemble into nanoparticles, which deliver the drugs into the target cells efficiently. Currently anticancer (gemcitabine , doxorubicin ), antiviral (dideoxycytidine ) and neuroprotective (adenosine ) drugs were used in this technology with great success. This project is devoted to revealing mechanisms of interaction of novel and highly promising squalene-based anti-cancer and neuroprotective drugs with cell membranes by means of in silico ccomputer simulations. The main goals of the project are the following: 1. To reveal how squalene-based drugs incorporate into the cell membranes, interact with membrane components and are released from the membranes on atomistic level of details. 2. To propose the ways of improving translocation of squalene-based drugs through the membranes in order to increase their therapeutic efficacy. The practical impact of the project is improving translocation of squalene-based drugs through the membranes and making it selective, which is of great interest for therapeutic applications of existing drugs and for creation of new compounds with desirable properties.

    more_vert
  • chevron_left
  • 1
  • 2
  • 3
  • 4
  • 5
  • chevron_right

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

Content report
No reports available
Funder report
No option selected
arrow_drop_down

Do you wish to download a CSV file? Note that this process may take a while.

There was an error in csv downloading. Please try again later.